AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

CYSTIC FIBROSIS-ASSOCIATED GENE

Summary

PROBLEM TO BE SOLVED: To provide a method for screening and detecting CF carrier, diagnosing CF and treating CF. ; SOLUTION: A CF protein gene usable for screening and detecting the CF carrier, diagnosing CF and treating CF is cloned, isolated and purified. ; COPYRIGHT: (C)2004,JPO&NCIPI

Supplementary Information

Inventor: LAP-CHEE TSUI | RIORDAN JOHN R | COLLINS FRANCIS S | ROMMENS JOHANNA M | IANNUZZI MICHAEL C | KEREM BAT-SHEVA | DRUMM MITCHELL L | BUCHWALD MANUEL
Priority Number: JP2004208694A
IPC Current: A01K0067027 | A61K003800 | A61K004800 | A61P000118 | A61P000300 | A61P000500 | A61P001100 | A61P004300 | C07H002104 | C07K000122 | C07K001400 | C07K001447 | C07K001600 | C07K001618 | C07K001628 | C12N000115 | C12N000119 | C12N000121 | C12N000510 | C12N001509 | C12N001512 | C12N001585 | C12P002102 | C12P002108 | C12Q000168 | G01N003353 | G01N0033566 | G01N0033577
Assignee Applicant: HSC Research & Development Ltd | Regents of the Unversity of Michigan
Title: CYSTIC FIBROSIS-ASSOCIATED GENE | Cystic fibrosis related gene
Usefulness: CYSTIC FIBROSIS-ASSOCIATED GENE | Cystic fibrosis related gene
Summary: USE The CF gene and its gene prod., nucleic acid probes and antibodies to the gene prod. can be used for screening for and detection of CF carriers, CF diagnosis and prenatal CF screening and diagnosis. The gene prod. and gene therapy can be used for CF therapy. The prods. can also be used to develop improved methods of treatment and to study the disease.
Novelty: Cystic fibrosis gene used to produce prods. for screening, detection, diagnosis, therapy and studying cystic fibrosis

Industry

Biomedical

Sub Group

DNA/Gene Engineering

Country/Region

Hong Kong

For more information, please click Here